Trexquant Investment LP Hutchmed (China) LTD Transaction History
Trexquant Investment LP
- $4.86 Billion
- Q1 2024
A detailed history of Trexquant Investment LP transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Trexquant Investment LP holds 48,109 shares of HCM stock, worth $823,626. This represents 0.02% of its overall portfolio holdings.
Number of Shares
48,109
Previous 19,753
143.55%
Holding current value
$823,626
Previous $357,000
126.33%
% of portfolio
0.02%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding HCM
# of Institutions
69Shares Held
14MCall Options Held
2.7KPut Options Held
3.7K-
General Atlantic LLC New York, NY4MShares$68.5 Million1.57% of portfolio
-
Schroder Investment Management Group London, X03.85MShares$65.9 Million0.08% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.57MShares$26.8 Million0.04% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.15MShares$19.8 Million0.3% of portfolio
-
Acadian Asset Management LLC Boston, MA487KShares$8.34 Million0.03% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.96B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...